11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now

4. Hologic Inc. (NASDAQ:HOLX)

Number of Hedge Fund Investors: 35

Being one of the Best Aesthetics Stocks, Hologic, Inc. (NASDAQ:HOLX) produces exclusive items to meet women’s healthcare requirements. The company has five business segments: diagnostics (44% of total sales), breast health (38%), surgery (16%), and skeletal health (2%). Although the business has historically prioritized breast health, the acquisition of Gen-Probe increased its focus on commercial testing. The greatest source of the company’s income is the United States (69%), which is followed by Europe (20%), Asia (8%), and other foreign markets (3%). The headquarters of Hologic are located in Bedford, Massachusetts. It is a market leader in women’s health, offering a variety of products that have set the benchmark for quality care.

Revenue of $987.9 million in Q4 2024 grew 4.5% year over year as a result of robust organic growth in several important segments. U.S. revenue climbed 4.2% year over year to $745.6 million. International revenue of $242.3 million increased by 5.4% year on year. In fiscal 2025, Hologic, Inc. (NASDAQ:HOLX) anticipates a strong implementation of its broad-based growth strategy.

Following its Q4 results and preliminary FY25 guidance, RBC Capital increased the price target on Hologic, Inc. (NASDAQ:HOLX) from $86 to $89 per share on November 5, 2024. In a research note to investors, the firm argued that the forecast is “achievable,” the operating margin objective of low 30% is “realistic,” and the management’s focus on M&A and buybacks is still “preferable.” According to RBC, the company’s management additionally highlighted its attempts to grow and enter new foreign markets, even though they have traditionally had lower profit margins than the U.S. business.

Jim Simons’s Renaissance Technologies was the largest stakeholder in the company among the funds in Insider Monkey’s database. It owns more than 2.8 million shares worth $229.57 million as of Q3.

ClearBridge Sustainability Leaders Strategy made the following comment about Hologic, Inc. (NASDAQ:HOLX) in its Q3 2023 investor letter:

“We continue to be active in positioning our holdings in the health care sector, in the quarter initiating a new position in Hologic, Inc. (NASDAQ:HOLX), a medical technology company focused on women’s health with leading positions in medical diagnostics, medical imaging systems and surgical devices. The company has used profits generated during the pandemic to diversify the business and increase recurring revenues, as well as return capital to shareholders. We believe Hologic is well-positioned to drive stable growth and improve profitability going forward and has a very strong balance sheet to fund future growth initiatives. Hologic’s products help detect cancer as well as a variety of infectious diseases, including COVID-19, thus improving health care outcomes for patients.”